GlaxoSmithKline PLC
NYSE:GSK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34.0708
45.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
GlaxoSmithKline PLC
Other Long-Term Assets
GlaxoSmithKline PLC
Other Long-Term Assets Peer Comparison
INDV
HIK
AGY
DPH
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
Other Long-Term Assets
£7.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
A
|
AstraZeneca PLC
NASDAQ:AZN
|
Other Long-Term Assets
$5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Indivior PLC
LSE:INDV
|
Other Long-Term Assets
$308m
|
CAGR 3-Years
41%
|
CAGR 5-Years
49%
|
CAGR 10-Years
13%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Other Long-Term Assets
$254m
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Other Long-Term Assets
£4.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is GlaxoSmithKline PLC's Other Long-Term Assets?
Other Long-Term Assets
7.9B
GBP
Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Other Long-Term Assets amounts to 7.9B GBP.
What is GlaxoSmithKline PLC's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
10%
Over the last year, the Other Long-Term Assets growth was 10%. The average annual Other Long-Term Assets growth rates for GlaxoSmithKline PLC have been 10% over the past three years , 9% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
